
DNA2 inhibitor C5
CAS No. 35973-25-2
DNA2 inhibitor C5( —— )
Catalog No. M24317 CAS No. 35973-25-2
DNA2 inhibitor C5 is a promising lead compound to develop sensitizers for cancer chemotherapeutics that cause replication stress and it also is a competitive and specific inhibitor of DNA2 nuclease activity (IC50: 20 μM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 69 | In Stock |
![]() ![]() |
5MG | 110 | In Stock |
![]() ![]() |
10MG | 178 | In Stock |
![]() ![]() |
25MG | 410 | In Stock |
![]() ![]() |
50MG | 605 | In Stock |
![]() ![]() |
100MG | 860 | In Stock |
![]() ![]() |
500MG | 1728 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameDNA2 inhibitor C5
-
NoteResearch use only, not for human use.
-
Brief DescriptionDNA2 inhibitor C5 is a promising lead compound to develop sensitizers for cancer chemotherapeutics that cause replication stress and it also is a competitive and specific inhibitor of DNA2 nuclease activity (IC50: 20 μM).
-
DescriptionDNA2 inhibitor C5 is a promising lead compound to develop sensitizers for cancer chemotherapeutics that cause replication stress and it also is a competitive and specific inhibitor of DNA2 nuclease activity (IC50: 20 μM). DNA2 inhibitor C5 inhibits nuclease, DNA dependent ATPase, helicase, and DNA binding activities of DNA2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorDNA2 nuclease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number35973-25-2
-
Formula Weight234.17
-
Molecular FormulaC10H6N2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:31.25 mg/mL (133.45 mM; Need ultrasonic)
-
SMILESO=C(C1=C(O)C2=CC=CC([N+]([O-])=O)=C2N=C1)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Binghui Shen, et al. Dna2 inhibitors for cancer treatment. US20170226063A1.
molnova catalog



related products
-
Acoramidis hydrochlo...
Acoramidis hydrochloride (Alxn2060 hydrochloride) is an orally active and selective kinetic stabilizer of WT and V122I- TTR (transthyretin) . Acoramidis hydrochloride is used in the study for transthyretin amyloidosis.
-
inS3-54-A26
inS3-54-A26, a novel inhibitor of the DNA-binding domain (DBD) of STAT3, suppresses tumor growth, metastasis and STAT3 target gene expression in vivo.
-
MTP 131 acetate
MTP 131 (acetate) is a small mitochondrially-targeted tetrapeptide.